Sign In
Buy MMEDF
$1.09
+0 (+0%)
At Close: Aug 17, 2022
5 Groovy Psychedelic Stocks to Buy
01:19pm, Friday, 08'th Jan 2021
Psychedelic stocks could have another “far out” year ahead with U.S. FDA support, as well as more clinical trials that are under way. The post 5 Groovy Psychedelic Stocks to Buy appeared first on
9 Growth Stocks That Are Priming Their Engines
01:53pm, Thursday, 07'th Jan 2021
There's no denying that 2021 will be a tricky year to navigate. But if you're feeling confident, here are some growth stocks to buy.
Mind Medicine: Why Kevin O'Leary Thinks This Psychedelics Company Is Just Getting Started
06:11am, Wednesday, 06'th Jan 2021
Are legal psychedelics a big growth opportunity? Mr. Wonderful seems to think so.
3 Psychedelic Stocks Taking Mental Health Seriously
12:49pm, Wednesday, 30'th Dec 2020
These psychedelic stocks are worth accumulating on corrections. The companies are holding clinical trials for mental health drugs.
Up 1,130% in 2020, Is MindMed Still a Buy?
07:34am, Wednesday, 23'rd Dec 2020
This clinical stage biotech's stock is still a risky purchase.
Mind Medicine (MindMed) Stock Price Increases Over 1,000% Since June: Why It Happened
03:57pm, Wednesday, 16'th Dec 2020
The stock price of Mind Medicine (MindMed) Inc (OTCQB: MMEDF) — a neuro-pharmaceutical company for psychedelic inspired medicines — increased over 1,000% since June as it went from $0.30 per share
Psychedelic Stocks News: Why MMEDF and NUMI Are Soaring Monday
12:05pm, Monday, 14'th Dec 2020
Psychedelic stocks are taking off on Monday with MindMed (MMEDF) and Numinus Wellness (LKYSF) seeing major spikes in trading. The post Psychedelic Stocks News: Why MMEDF and NUMI Are Soaring Monday ap
MMEDF Stock: 9 Things for Investors to Know About Shroom Boom Play MindMed
12:02pm, Monday, 14'th Dec 2020
MindMed (MMEDF) is seeing a massive increase in its stock on Monday despite a lack of news from the psychedelic drug company. The post MMEDF Stock: 9 Things for Investors to Know About Shroom Boom Pla
MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy
07:30am, Monday, 14'th Dec 2020
Provides Clinical Development Update on 18-MC Based on positive pre-IND meeting with U.S. Food and Drug Administration (FDA), MindMed is now prepared to open an Investigational New Drug (IND) in Augus
MMEDF Stock: Why Psychedelics Play Mind Medicine Is Soaring Today
03:22pm, Friday, 11'th Dec 2020
MMEDF stock is climbing Friday thanks to news psychedelics company MindMed just raised another $27 million. Here's what you should know.
Is MindMed Creating The Tesla Of Mental Health? Thoughts From CEO JR Rahn, Investor Kevin O'Leary
09:38am, Thursday, 10'th Dec 2020
Mind Medicine (OTC: MMEDF) Co-Founder and CEO J.R. Rahn and investor Kevin O'Leary spoke this week at the inaugural Benzinga Global Small Cap Conference.
This Magic Mushroom Stock Is Worth Your Money Right Now
07:30am, Thursday, 10'th Dec 2020
Psychedelic medicines are the future, and this company is on the cutting edge.
MindMed: Severely Undervalued With Massive Upside Yet To Come
04:13pm, Thursday, 03'rd Dec 2020
MindMed is a biotech psychedelic medicine company focused on the clinical development of LSD, Ibogaine, MDMA, DMT, and psilocybin for anxiety, depression, addiction, ADHD, and more. Diverse and robust
3 Psychedelic Stocks to Invest In the Future of Medicine
03:08pm, Tuesday, 01'st Dec 2020
These psychedelic stocks have done extremely well despite the novel coronavirus pandemic and are set for major gains in the new normal. The post 3 Psychedelic Stocks to Invest In the Future of Medicin
How MindMed Uses Tech To Innovate, Deploy Psychedelic Mental Health Therapies
08:11am, Wednesday, 25'th Nov 2020
In an exclusive to Benzinga, Mind Medicine (MindMed) Inc (OTC: MMEDF), a leading medicine biotech company in psychedelics, on Tuesday revealed the introduction of a division known as Albert, to help
